The Company Audit
Chapter 13 - The Company Audit
Independent auditors entered Whitmore Medical.
They found two clinical databases.
The internal database included complications, failed calibrations, and unexplained performance drops.
The external database excluded enough failures to meet marketing thresholds.
Margaret claimed standard statistical cleaning.
Experts found no legitimate method supporting the removals.
Hospitals suspended use of several devices pending review.
The company established a patient-support fund before litigation concluded.
Daniel stepped down as executive vice president.
The board appointed Grace Chen, head of clinical operations, as interim chief executive.
Nora did not take control.
She did not own the company.
She owned her research and the right to seek correction.
May you like
Grace separated the new perfusion model from Whitmore’s proprietary claims and negotiated an independent safety license.
The technology could continue helping surgeons without remaining dependent on the family that tried to silence its author.
